Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review

Cited by (487)

Items 101–200 of 487

1. Are we really active in the prevention of obesity and type 2 diabetes at the community level?
   Matti I.J. Uusitupa, Jaakko O. Tuomilehto, Pekka Puska · 2011 · Nutrition Metabolism and Cardiovascular Diseases
2. Role of matrix metalloproteinases in chronic wound healing: diagnostic and therapeutic implications
   Yanhan Ren, Guosheng Gu, Min Yao, Vickie R. Driver · 2014 · Chinese Medical Journal
3. Effectiveness of a Group Support Lifestyle Modification (GSLiM) Programme among Obese Adults in Workplace: A Randomised Controlled Trial
   Siti Noraida Jamal, Foong Ming Moy, Mohd Nahar Azmi Mohamed, Firdaus Mukhtar · 2016 · PLoS ONE
4. Reconsidering the age thresholds for type II diabetes screening in the U.S
   Chung, Sukyung, Azar, Kristen M.J., Baek, Marshall, Lauderdale, Diane S., Palaniappan, Latha P. · 2014 · American Journal of Preventive Medicine
5. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial
   José Leal, Dariush Ahrabian, Melanie Jane Davies, L J Gray, Kamlesh K. Khunti, Thomas E. Yates, Alastair McIntosh Gray · 2017 · BMJ Open
6. Preventing type 2 diabetes and cardiovascular disease in women with gestational diabetes – The evidence and potential strategies
   Graziano Di Cianni, Emilia Lacaria, Cristina Lencioni, Veronica Resi · 2018 · Diabetes Research and Clinical Practice
7. Coste-efectividad de la intervención sobre el estilo de vida para prevenir la diabetes tipo 2
   Ramon Sagarra-Alamo, B Costa, J.J. Cabré, Oriol Solà-Morales, Francisco Barrio · 2013 · Revista Clínica Española
8. The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru
   María Kathia Cárdenas, Andrew J. Mirelman, Cooper J. Galvin, María Lazo-Porras, Miguel Eduardo Pinto, J. Jaime Miranda, Robert H. Gilman · 2015 · BMC Health Services Research
9. The Future of Diabetes Education
   Annette Lenzi Martin, Ruth D. Lipman · 2013 · The Science of Diabetes Self-Management and Care
10. Alternative HbA1c Cutoffs to Identify High-Risk Adults for Diabetes Prevention
    Xiaohui Zhuo, Ping Zhang, Elizabeth Selvin, Thomas J. Hoerger, Ronald T. Ackermann, Rui Li, Kai McKeever Bullard, Edward W. Gregg · 2012 · American Journal of Preventive Medicine
11. Stratified Patient-Centered Care in Type 2 Diabetes
    Annabelle S. Slingerland, William H. Herman, Ken Redekop, Rob F. Dijkstra, J. Wouter Jukema, Louis Wilhelmus Niessen · 2013 · Diabetes Care
12. Global Prevention And Control Of Type 2 Diabetes Will Require Paradigm Shifts In Policies Within And Among Countries
    K.M. Venkat Narayan, Justin Basile Echouffo-Tcheugui, Viswanathan Mohan, Mohammed Kumail Ali · 2012 · Health Affairs
13. Global Perspective on Diabetic Foot Ulcerations
    Thanh Dinh · 2011 · InTech eBooks
14. A randomized controlled study to evaluate the effect of pharmacist-led educational intervention on glycemic control, self-care activities and disease knowledge among type 2 diabetes patients
    Allah Bukhsh, Muhammad Sarfraz Nawaz, Hafiz Sajjad Ahmed, Tahir Mehmood Khan · 2018 · Medicine
15. Development of Functional or Medical Foods for Oral Administration of Insulin for Diabetes Treatment: Gastroprotective Edible Microgels
    Quancai Sun, Zipei Zhang, Ruojie Zhang, Ruichang Gao, David Julian McClements · 2018 · Journal of Agricultural and Food Chemistry
16. Association between processes of diabetes care and health care utilization in patients with diabetes: Evidence from a nationally representative US sample
    Dimittri Delevry, Anh Ho, Quang A. Le · 2020 · Journal of Diabetes
17. Estimating costs of diabetes complications in people <65 years in the U.S. using panel data
    Wenya Yang, Inna Cintina, Thomas J. Hoerger, Simon J. Neuwahl, Hui Shao, Michael Laxy, Ping Zhang · 2020 · Journal of Diabetes and its Complications
18. Cost-Effectiveness of Reducing Glycaemic Episodes Through Community Pharmacy Management of Patients with Type 2 Diabetes Mellitus
    Delia V. Hendrie, Ted R. Miller, Richard John Woodman, Kreshnik Hoti, Jeff Hughes · 2014 · The Journal of Primary Prevention
19. Early Identification of Type 2 Diabetes
    K.M. Venkat Narayan, Juliana C.N. Chan, Viswanathan Mohan · 2010 · Diabetes Care
20. A case study of using the He Pikinga Waiora Implementation Framework: challenges and successes in implementing a twelve-week lifestyle intervention to reduce weight in Māori men at risk of diabetes, cardiovascular disease and obesity
    JOHN G. OETZEL, Moana Rarere, Ray Wihapi, Carey Manuel, Jade Tapsell · 2020 · International Journal for Equity in Health
21. Using polyphenols as a relevant therapy to diabetes and its complications, a review
    José João Caires Serina, Paula C. Castilho · 2021 · Critical Reviews in Food Science and Nutrition
22. Differences between genders in relation to factors associated with risk of diabetic foot in elderly persons: A cross-sectional trial
    Fabiana Magalhães Navarro-Peternella, Ana Patrícia A. Torquato Lopes, Guilherme Oliveira de Arruda, Élen Ferraz Teston, Sônia Silva Marcon · 2016 · Journal of Clinical & Translational Endocrinology
23. Telehealth Technologies: Changing the Way We Deliver Efficacious and Cost-Effective Diabetes Self-Management Education
    Karen Fitzner, E. A. Heckinger, Katrina M. Tulas, James E. Specker, June M. McKoy · 2014 · Journal of Health Care for the Poor and Underserved
24. Decision models of prediabetes populations: A systematic review
    Leal, Jose, Morrow, Liam Mc, Khurshid, Waqar, Pagano, Eva, Feenstra, Talitha · 2019 · Diabetes, Obesity and Metabolism
25. The Economic Costs of Noncommunicable Diseases in the Pacific Islands : A Rapid Stocktake of the Situation in Samoa, Tonga, and Vanuatu
    Ian Anderson · 2013 · World Bank, Washington, DC eBooks
26. Use of Medical Services and Medicines Attributable to Diabetes in Sub-Saharan Africa
    Jonathan Betz Brown, Kaushik Laxmidas Ramaiya, Stéphane Besançon, Paul Rheeder, Clarisse MAPA-TASSOU, Jean Claude Mbanya, Katarzyna Kissimova‐Skarbek, Eva Wangechi Njenga, Eva Wangui Muchemi, Harrison Kiambuthi Wanjiru et al. · 2014 · PLoS ONE
27. Systematic review of effectiveness and cost-effectiveness of lifestyle interventions to improve clinical diabetes outcome measures in women with a history of GDM
    Sumali S. Hewage, Shishi Wu, Nithya Neelakantan, Joanne Yoong · 2019 · Clinical Nutrition ESPEN
28. Do Perceptions of Empowerment Affect Glycemic Control and Self-Care Among Adults with Type 2 Diabetes?
    Melba Sheila D’Souza, Subrahmanya Nairy Karkada, Nancy P. Hanrahan, Ramesh Venkatesaperumal, Anandhi Deva Amirtharaj · 2015 · Global Journal of Health Science
29. The Economic Costs of Noncommunicable Diseases in the Pacific Islands
    World Bank · 2012
30. Determination of the long term diabetes related complications and cardiovascular events using UKPDS risk engine and UKPDS outcomes model in a representative western Indian population
    Pinaki Ghosh, Amit Dattatraya Kandhare, Kiran S. Raygude, V. Shiva Kumar, Anuchandra Ramchandra Rajmane, Mohammad Adil, Subhash L. Bodhankar · 2012 · Asian Pacific Journal of Tropical Disease
31. Prevention of Diabetes after Gestational Diabetes: Better Translation of Nutrition and Lifestyle Messages Needed
    Sharleen L. O'Reilly · 2014 · Healthcare
32. Health expenditures spent for prevention, economic performance, and social welfare
    Fuhmei Wang, Jung‐Der Wang, Yu-Xiu Huang · 2016 · Health Economics Review
33. Integrating substance abuse care with community diabetes care: implications for research and clinical practice
    Udi E. Ghitza, Li-Tzy T. Wu, Betty Tai · 2013 · Substance Abuse and Rehabilitation
34. Health service utilization and related costs attributable to diabetes
    Kate O’Neill, Sheena McHugh, ML Tracey, Tony Fitzgerald, Patricia M. Kearney · 2018 · Diabetic Medicine
35. Economic Impact of Diabetes in South Asia: the Magnitude of the Problem
    Kavita Singh, K.M. Venkat Narayan, Karen N. Eggleston · 2019 · Current Diabetes Reports
36. Lifestyle interventions for diabetes mellitus type 2 prevention
    Ramon Sagarra-Alamo, B Costa, J.J. Cabré, Oriol Solà-Morales, Francisco Barrio · 2013 · Revista Clínica Española (English Edition)
37. Monitoring the Prognosis of Diabetic Foot Ulcers: Predictive Value of Neutrophil-to-Lymphocyte Ratio and Red Blood Cell Distribution Width
    Gökhun Arıcan, H. Kahraman, A. Özmeriç, S. Iltar, K. Alemdaroğlu · 2020 · International Journal of Lower Extremity Wounds
38. The Pathogenesis of the Diabetic Foot Ulcer: Prevention and Management
    F. Aguilar, Juan Miguel Teran‐Soto, Jorge Escobedo de la Pen · 2011 · InTech eBooks
39. Diet and Lifestyle Guidelines for Diabetes: Evidence Based Ayurvedic Perspective
    Rohit Sharma, PK Prajapati · 2014 · Romanian Journal of Diabetes Nutrition and Metabolic Diseases
40. Insurance coverage and diabetes quality indicators among patients with diabetes in the US general population
    Emily D. Doucette, Joanne Salas, Jing Wang, Jeffrey F. Scherrer · 2017 · Primary care diabetes
41. Liquid chromatography tandem mass spectrometry for the simultaneous determination of metformin and pioglitazone in rat plasma: Application to pharmacokinetic and drug-drug interaction studies
    Mohamed Saleh Elgawish, Sally Nasser, Ismail Salama, Abbas M. Abbas‎, Samia M. Mostafa · 2019 · Journal of Chromatography B
42. CASALUD: an innovative health-care system to control and prevent non-communicable diseases in Mexico
    ROBERTO C. TAPIA-CONYER, Héctor Gallardo‐Rincón, Rodrigo Saucedo-Martínez · 2013 · Perspectives in Public Health
43. Pilot randomized controlled trial of a complex intervention for diabetes self-management supported by volunteers, technology, and interprofessional primary health care teams
    Gina Agarwal, Jessica Gaber, Julie Anne Richardson, Dee A. Mangin, Jenny Ploeg, Ruta Kristina Valaitis, Graham J. Reid, Larkin Lamarche, Fiona Parascandalo, Dena Javadi et al. · 2019 · Pilot and Feasibility Studies
44. A Key To Slower Health Spending Growth Worldwide Will Be Unlocking Innovation To Reduce The Labor-Intensity Of Care
    Michael Macdonnell, Ara Wardkes Darzi · 2013 · Health Affairs
45. Progression to type 2 diabetes, healthcare utilization, and cost among pre-diabetic patients with or without comorbid hypertension
    Bruce H. Francis, Xue Song, L. M. Andrews, Das Purkayastha, Nicole Princic, Robert Sedgley, Amy E. Rudolph · 2011 · Current Medical Research and Opinion
46. Severely obese people with diabetes experience impaired emotional well-being associated with socioeconomic disadvantage: Results from diabetes MILES – Australia
    John B. Dixon, Jessica L. Browne, Gavin William Lambert, Kay Jones, Prasuna Reddy, Frans Pouwer, Jane Speight · 2013 · Diabetes Research and Clinical Practice
47. Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases: a randomized controlled trial
    Marieke F. van Wier, Jeroen Lakerveld, Sandra D.M. Bot, Mai J. M. Chinapaw, Giel Nijpels, Maurits W. van Tulder · 2013 · BMC Family Practice
48. Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany
    Gregory Gordon Greiner, Karl M. F. Emmert-Fees, Jana Becker, Wolfgang Rathmann, Barbara Thorand, Annette Peters, Anne S. Quante, Lars Schwettmann, Michael Laxy · 2020 · Acta Diabetologica
49. Decrements in health‐related quality of life associated with adverse events in people with diabetes
    Mi Jun Keng, José Leal, Louise J. Bowman, Jane Armitage, Borislava Mihaylova, ASCEND Study Collaborative Group · 2021 · Diabetes Obesity and Metabolism
50. Diabetes and quality of life: Comparing results from utility instruments and Diabetes-39
    Gang Chen, Angelo Iezzi, John R. Mckie, Munir Ahmed Khan, Jeff R. J. Richardson · 2015 · Diabetes Research and Clinical Practice
51. Understanding the experience of care managers and relationship with patient outcomes: the COMPASS initiative
    Karen J. Coleman, Tani Hemmila, Mark D. Valenti, Nasya Smith, Rachel Quarrell, Lynnice K. Ruona, Emily Brandenfels, Barbara Hann, Todd Hinnenkamp, Margarita D. Parra et al. · 2016 · General Hospital Psychiatry
52. Non-Mydriatic Fundus Retinography in Screening for Diabetic Retinopathy: Agreement Between Family Physicians, General Ophthalmologists, and a Retinal Specialist
    Leonardo Provetti Cunha, Evelyn Alvernaz Figueiredo, Henrique Pereira Araújo, Luciana Virgínia Ferreira Costa-Cunha, Carolina Ferreira Costa, José de Melo Costa Neto, Aline Mota Freitas Matos, Marise Machado de Oliveira, Marcus Gomes Bastos, Mário Luiz Ribeiro Monteiro · 2018 · Frontiers in Endocrinology
53. State-level diabetes-attributable mortality and years of life lost in the United States
    Maria Liliana Alva, Thomas J. Hoerger, Ping Zhang, Yiling J. Cheng · 2018 · Annals of Epidemiology
54. Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation
    Alaa F. Badawi, Mortaz, Wessman, Duncan, Gray · 2012 · ClinicoEconomics and Outcomes Research
55. Economic evaluation of physical activity interventions for type 2 diabetes management: a systematic review
    Barbosa, Ana, Whiting, Stephen, Ding, Ding, Brito, João, Mendes, Romeu · 2022 · European Journal of Public Health
56. Interpretable machine learning method to predict the risk of pre-diabetes using a national-wide cross-sectional data: evidence from CHNS
    Xiaolong Li, Fan Ding, Lu Zhang, Shi Zhao, Zengyun Hu, Zhanbing Ma, Li Feng, Yuhong Zhang, Yiyi Zhao, Yu Zhao · 2025 · BMC Public Health
57. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes
    John J. Ko, Jackie Lu, Karen L. Rascati, Eileen M. Stock, Joyce Juan, Kangho Suh, Yoona A. Kim, Patricia A. Tabor, Paul J. Godley · 2016 · Journal of Managed Care & Specialty Pharmacy
58. Association of diabetes type and chronic diabetes complications with early exit from the labour force: register-based study of people with diabetes in Finland
    Olli Kurkela, Leena Forma, Pirjo Ilanne‐Parikka, Jaakko Nevalainen, Pekka Rissanen · 2021 · Diabetologia
59. Preventing Type 2 Diabetes Mellitus: A Call for Personalized Intervention
    Harry S. Glauber, Eddy Karnieli · 2013 · The Permanente Journal
60. Improvement of Fasting Plasma Glucose Level After Ingesting Moderate Amount of Dietary Fiber in Japanese Men With Mild Hyperglycemia and Visceral Fat Obesity
    Akira Kobayakawa, Tomoo Suzuki, Takao Ikami, Morio Saito, Daisuke Yabe, Yutaka Seino · 2013 · Journal of Dietary Supplements
61. Diabetes self‐risk assessment questionnaires coupled with a multimedia health promotion campaign are cheap and effective tools to increase public awareness of diabetes in a large Chinese population
    Y. L. Zhang, Weiguo Gao, Zhenmiao Pang, J. P. Sun, Shuu‐Jiun Wang, F. Ning, Xin Song, Anil Kapur, Qing Qiao · 2012 · Diabetic Medicine
62. The Psychometric Testing of the Diabetes Health Promotion Self-Care Scale
    Ruey‐Hsia Wang, Li‐Ying Lin, Chung‐Ping Cheng, Min‐Tao Hsu, Chia‐Chan Kao · 2012 · Journal of Nursing Research
63. Costs, Benefits, and Effectiveness of Interventions for the Prevention, Treatment, and Control of Cardiovascular Diseases and Diabetes in Africa
    Shanthi Mendis, Oleg Chestnov · 2013 · Progress in Cardiovascular Diseases
64. ‘Personalized Medicine’ To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?
    Allen M. Spiegel, Meredith A. Hawkins · 2012 · Health Affairs
65. Evidence insufficient to confirm the value of population screening for diabetes and hypertension in low- and-middle-income settings
    Solange Durão, Oluwayemisi Ajumobi, Tamara Kredo, Celeste E. Naude, Naomi Sharlene Levitt, Krisela Steyn, Debbie Bradshaw, Taryn Young · 2015 · South African Medical Journal
66. Suicide Prevention Among College Students Before and During the COVID-19 Pandemic: Protocol for a Systematic Review and Meta-analysis
    Yunyu Xiao, Rachel Hinrichs, Nina C. Johnson, Amanda McKinley, Joan M. Carlson, Jon D. Agley, Paul S. F. Yip · 2021 · JMIR Research Protocols
67. Management of diabetic retinopathy.
    Darcy Ellis, Philip I. Burgess, Petros Kayange · 2013 · Europe PMC (PubMed Central)
68. Custo-efetividade e impacto orçamentário da saxagliptina como terapia adicional à metformina para o tratamento do diabetes mellitus tipo 2 no sistema de saúde suplementar do Brasil
    Marcelo Eidi Nita, Freddy Goldberg Eliaschewitz, Eliane Ribeiro, Elio Fernando Asano, Elias Barbosa, Maíra Libertad Soligo Takemoto, Bonnie M.K. Donato, Roberto Del Valhe Abi Rached, Elaine Rahal · 2012 · Revista da Associação Médica Brasileira
69. Trends in the prevalence of physical and functional disability among Spanish elderly suffering from diabetes (2000–2007)
    Maria Angeles Martinez-Huedo, Ana López‐de‐Andrés, Valentín Hernández‐Barrera, Domingo Palacios‐Ceña, Pilar Carrasco‐Garrido, David Martínez Hernández, Rodrigo Jiménez‐García · 2011 · Diabetes Research and Clinical Practice
70. Epidemiology and Health Care Cost of Diabetic Foot Problems
    Jeremy J. Cook, Donald C. Simonson · 2012 · Humana Press eBooks
71. Circulating Concentrations of Advanced Glycation end Products, its Association With the Development of Diabetes Mellitus
    Itzel Uribe Jiménez, Eulises Díaz‐Díaz, Jorge Salmerón, Julia Pérez Ramos, Mario Cárdenas León, José Antonio Alvarado Ríos, Juan Carlos Auriostigue Bautista, Ricardo Correa‐Rotter, Carlos Alberto Aguilar-Salinas, Fernando Larrea · 2017 · Archives of Medical Research
72. Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey
    Thi Tuyet Mai Kieu, Hong Nhung Trinh, Huy Tuan Kiet Pham, Thanh Nguyen, Junice Yi Siu Ng · 2020 · BMJ Open
73. Cost-Effectiveness of a Community-Based Weight Control Intervention Targeting a Low-Socioeconomic-Status Mexican-Origin Population
    Kimberly J. Wilson, H. Shelton Brown, Elena Bastida · 2014 · Health Promotion Practice
74. Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
    Marcelo Eidi Nita, Freddy Goldberg Eliaschewitz, Eliane Ribeiro, Elio Fernando Asano, Elias Barbosa, Maíra Libertad Soligo Takemoto, Bonnie M.K. Donato, Roberto Del Valhe Abi Rached, Elaine Rahal · 2012 · Revista da Associação Médica Brasileira (English Edition)
75. Improving comprehensive care for patients with diabetes
    Tamar Kutz, Jameson M Roszhart, Marshall Hale, Virginia Dolan, Gerald Suchomski, Cassie Jaeger · 2018 · BMJ Open Quality
76. Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome
    Simona Moscatiello, Raffaella Di Luzio, Anna Simona Sasdelli, Giulio Marchesini · 2011 · Expert Opinion on Pharmacotherapy
77. Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials
    Padam Kanta Dahal, Lal Bahadur Rawal, Rashidul Alam Mahumud, Grish Paudel, Tomohiko Sugishita, Corneel Vandelanotte · 2022 · International Journal of Environmental Research and Public Health
78. Treatment of Hyperglycaemia in Type 2 Diabetic Patients in a Primary Care Population Database in a Mediterranean Area (Catalonia, Spain)
    Manel Mata‐Cases · 2014 · Journal of Diabetes & Metabolism
79. A systematic review on costs and cost-effectiveness of screening and prevention of type 2 diabetes in women with prior gestational diabetes: Exploring uncharted territory
    Amber Werbrouck, Masja Schmidt, Koen D. Putman, Katrien Benhalima, Nick Verhaeghe, Lieven Annemans, Steven Simoens · 2018 · Diabetes Research and Clinical Practice
80. Results of a Mixed-Methods Evaluation of Partnerships for Health: A Quality Improvement Initiative for Diabetes Care
    Stewart B. Harris, Jann Paquette‐Warren, Sharon E. Roberts, Meghan Fournie, A. Thind, Bridget L. Ryan, Chris M. Thorpe, Amanda Lee Terry, Judith Belle Brown, Moira Stewart et al. · 2013 · The Journal of the American Board of Family Medicine
81. Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton
    Pascal Bovet, Hirsiger, Emery, D.A. Bernardini, Rossier, Trebeljahr, Hagon · 2011 · Diabetes Metabolic Syndrome and Obesity
82. Improving Machine Learning Diabetes Prediction Models for the Utmost Clinical Effectiveness
    Juyoung Shin, Joonyub Lee, Taehoon Ko, Kang Hyuck Lee, Yera Choi, Hun‐Sung Kim · 2022 · Journal of Personalized Medicine
83. Opportunistic Screening For Diabetes And Prediabetes Using Hemoglobin A1C In An Urban Primary Care Setting
    N. Sohler, Brenda Matti‐Orozco, Edwin Young, Xuan Li, Edward W. Gregg, Mohammed Kumail Ali, Kai McKeever Bullard, Jeanine Albu · 2015 · Endocrine Practice
84. Expenditures of medicine use in hypertensive/diabetic elderly and physical activity and engagement in walking: cross secctional analysis of SABE Survey
    Denise Rodrigues Bueno, Maria de Fátima Nunes Marucci, Luís Alberto Gobbo, Manuela de Almeida-Roediger, Yeda Aparecida de Oliveira Duarte, Maria Lúcia Lebrão · 2017 · BMC Geriatrics
85. E‐health education interventions on HbA1c in patients with type 1 diabetes on intensive insulin therapy: A systematic review and meta‐analysis of randomized controlled trials
    Eva Feigerlová, Abderrahim Oussalah, Stéphane Zuily, Stéphanie Sordet, Marc Braun, Jean‐Louis Guéant, Bruno Guerci · 2020 · Diabetes/Metabolism Research and Reviews
86. The Lifestyle Intervention for the Treatment of Diabetes study (LIFT Diabetes): Design and baseline characteristics for a randomized translational trial to improve control of cardiovascular disease risk factors
    Katula, Jeffrey A., Kirk, Julienne K., Pedley, Carolyn F., Savoca, Margaret R., Effoe, Valery S., Bell, Ronny A., Bertoni, Alain G. · 2017 · Contemporary Clinical Trials
87. How to dampen the surge of non-communicable diseases in Southeast Asia: insights from a systematic review and meta-analysis
    Manuela Katharina Fritz, Hanna Fromell · 2021 · Health Policy and Planning
88. Comparing incident diabetes as defined by fasting plasma glucose or by HbA1c. The AusDiab, Inter99 and DESIR studies
    Soraya Soulimane, D. Simon, Jonathan E. Shaw, Paul Zimmet, Sylviane Vol, Dorte Vistisen, Dianna J. Magliano, K. Borch‐Johnsen, Beverley Balkau · 2011 · Diabetic Medicine
89. Barriers to Postpartum Glucose Intolerance Screening in an Italian Population
    Paola Quaresima, Federica Visconti, EUSEBIO D. CHIEFARI, Luigi Puccio, DANIELA PATRIZIA FOTI, Roberta Venturella, Raffaella Vero, Antonio Brunetti, Costantino Di Carlo · 2018 · International Journal of Environmental Research and Public Health
90. Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists
    Sasha van Katwyk, Ya-Ping Jin, Graham E. Trope, Yvonne M. Buys, Lisa Masucci, Richard Wedge, John G. Flanagan, Michael Henry Brent, Sherif R. El-Defrawy, Hong Tu et al. · 2017 · Value in Health
91. Health Care Providers’ Knowledge, Attitudes, and Practices and the Association With Referrals to the National Diabetes Prevention Program Lifestyle Change Program
    LaShonda R. Hulbert, Xuanping Zhang, Boon Peng Ng, Kunthea Nhim, Tamkeen Khan, Michael J. Cannon · 2021 · American Journal of Health Promotion
92. Assessment of the Direct Medical Costs of Type 2 Diabetes Mellitus and its Complications in Turkey
    S Malhan, E Öksüz, Steven M. Babineaux, Ali Ertekin, James P Palmer · 2014 · Endocrinology research and practice.
93. Analysing predictors for future high-cost patients using German SHI data to identify starting points for prevention
    Justyna Hartmann, Svenja Jacobs, Sveja Eberhard, Thomas von Lengerke, Volker Eric Amelung · 2016 · European Journal of Public Health
94. Factors Associated With Avoiding Health Care Among Community-Dwelling Medicare Beneficiaries With Type 2 Diabetes
    Boon Peng Ng, Jacqueline B. LaManna, Samuel D. Towne, Brian C. Peach, Qing He, Chanhyun Park · 2020 · Preventing Chronic Disease
95. Incremental Cost-Effectiveness Analysis of Gestational Diabetes Mellitus Screening Strategies in Singapore
    Pin Yu Chen, Eric Andrew Finkelstein, Mor Jack Ng, Fabian K. P. Yap, George SH Yeo, Victor Samuel Rajadurai, Yap Seng Chong, Peter David Gluckman, Seang‐Mei Saw, Kenneth Y. C. Kwek et al. · 2015 · Asia Pacific Journal of Public Health
96. Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review
    Yunyu Huang, Qiyun Zhou, Flora M. Haaijer‐Ruskamp, Maarten Jacobus Postma · 2014 · BMC Nephrology
97. The Business Case for a Diabetes Self-Management Intervention in a Community General Hospital
    Ashley Micklethwaite, Carol A. Brownson, Mary L. O'Toole, Kerry E. Kilpatrick · 2012 · Population Health Management
98. Associations of Intensive Lifestyle Intervention in Type 2 Diabetes With Health Care Use, Spending, and Disability
    Peter J. Huckfeldt, Chris Frenier, Nicholas M. Pajewski, Mark Andrew Espeland, Anne L. Peters, Ramon Casanova, Xavier Pi‐Sunyer, Lawrence Jay Cheskin, Dana P. Goldman · 2020 · JAMA Network Open
99. Current role of short‐term intensive insulin strategies in newly diagnosed type 2 diabetes (短期胰岛素强化治疗策略对初诊2型糖尿病患者的作用)
    Wen Xu, Jianping Weng · 2013 · Journal of Diabetes
100. Incidence of Self-Reported Diabetes in New York City, 2002, 2004, and 2008
     Bahman P. Tabaei, Shadi Chamany, CR Driver, Bonnie D. Kerker, Lynn Dee Silver · 2012 · Preventing Chronic Disease